Loading clinical trials...

National Marrow Donor Program Long-Term Donor Follow-Up | Clinical Trials | Clareo Health

COMPLETEDNCT01362179

National Marrow Donor Program Long-Term Donor Follow-Up

This is an observational study of unstimulated bone marrow (BM) and filgrastim-mobilized peripheral blood stem cell (PBSC) donors. The primary goal is to evaluate the hypothesis that the incidence of ...

Lead sponsor: Center for International Blood and Marrow Transplant Research•28 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1

Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation

NCT07162038 · Hematologic Malignancies, Hematologic Neoplasms

RECRUITING

Prospective Validation of the OHI Index

NCT05882175 · HLH, Hemophagocytic Lymphohistiocytoses, and more

RECRUITING

UWCCC Molecular Tumor Board Registry

NCT03023202 · Hematologic Neoplasms, Solid Neoplasm

RECRUITING

The ACC Preclinical Research Platform for Precision Oncology

NCT06339541 · Solid Tumor, Hematologic Neoplasms

Active Not RecruitingPhase 1/2

Optimizing PTCy Dose and Timing

NCT03983850 · Graft Versus Host Disease, Hematologic Neoplasms

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 20, 2020Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment21,974

Start dateOct 2010

Last updatedOct 20, 2020

Condition

Hematologic Neoplasms

Locations shown

City of Hope

Duarte, California

National Marrow Donor Program Northern California & Northwest District

Oakland, California

National Marrow Donor Program Southern California & Southwest District

Santa Ana, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 20, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

National Marrow Donor Program Long-Term Donor Follow-Up

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation

Prospective Validation of the OHI Index

UWCCC Molecular Tumor Board Registry

The ACC Preclinical Research Platform for Precision Oncology

Optimizing PTCy Dose and Timing

Trial snapshot

Condition

Locations shown

For caregivers